Both in Biotechnology
Inhibrx Biosciences vs Taysha Gene Therapies
Over the past year INBX returned +5.8% and TSHA returned +2.1%; their daily moves had a correlation of 0.31.
INBX +5.8% TSHA +2.1%Growth of $1, one year, split-adjusted
| Metric | INBX | TSHA |
|---|---|---|
| Price | $86.76 | $4.36 |
| Market cap | $1.28B | $1.42B |
| Today | +7.01% | +6.60% |
| 1 month | −7.1% | −0.7% |
| 6 months | −38.8% | −37.5% |
| Year to date | +9.8% | −20.7% |
| 1 year | +6.5% | −2.2% |
| Revenue growth (YoY) | −100.0% | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 259.0× |
| Net cash | -$42.9M | $406.1M |
| Dividend yield | — | — |
| Volatility (60d) | 88.8% | 58.8% |
| Short % of float | 35.5% | 17.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).